Health tech firm Revvity misses Q3 revenue estimates, announces $1 bln buyback program

Revvity

27/10/2025 10:11

Overview

Revvity Q3 revenue of $699 mln missed analyst expectations

Adjusted EPS from continuing operations was $1.18, down from $1.28 last year

Company authorizes new $1 bln share repurchase program

Outlook

Revvity updates 2025 revenue guidance to $2.83-$2.88 bln due to currency changes

Company reaffirms 2025 organic growth guidance of 2% to 4%

Revvity raises 2025 adjusted EPS guidance to $4.90-$5.00

Result Drivers

STRATEGIC PARTNERSHIPS - CEO Prahlad Singh attributes Q3 performance to key innovations and strategic partnerships

SHARE REPURCHASE - Co authorizes new $1 bln share repurchase program, replacing prior program

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$698.94 mln
$700.45 mln (16 Analysts)
Q3 EPS
$0.40
Q3 Adjusted EPS continuing operations
$1.18


Press Release: ID:nBw7gg2X4a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)